The DOI matches its Crossref record.
Twenty‐four‐hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole
Abstract
SUMMARY: Simultaneous 24‐hour intragastric acidity and plasma gastrin concentrations were measured in 12 duodenal ulcer patients before and on the twenty‐eighth day of treatment with either ranitidine 150 mg b.d. or omeprazole 20 mg o.m. Median integrated 24‐hour intragastric acidity was decreased significantly from 1148 to 490 and 36 mmol. hour litre−1 during treatment with ranitidine and omeprazole, respectively, whilst median intragastric 24‐hour plasma gastrin was raised significantly from 328 to 799 and 1519 pmol. hour litre−1 respectively. When the results of all 48 experiments were considered together, there was a significant inverse correlation between the 24‐hour integrated values for intragastric acidity and plasma gastrin concentration. Both drugs caused a significant elevation of plasma gastrin throughout the 24 hours, although ranitidine had no effect on intragastric acidity from 1900 to 2200 hours. When compared with similar profiles of acidity and gastrin in pernicious‐anaemia patients, the modest elevations of plasma gastrin observed in this study suggest that neither drug will be associated with clinically relevant enterochromaffin‐like cell proliferation in duodenal ulcer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 44
- 10.1016/S0140-6736(75)90434-1 · doi:10.1016/s0140-6736(75)90434-1
- 10.1172/JCI107960 · doi:10.1172/jci107960
- 10.1056/NEJM197508212930802 · DOI · Paper page
- 10.1136/gut.16.3.186 · doi:10.1136/gut.16.3.186
- 10.1136/gut.17.2.133 · doi:10.1136/gut.17.2.133
- 10.1136/gut.17.3.161 · doi:10.1136/gut.17.3.161
- 10.1136/gut.20.5.404 · DOI
- 10.1016/S0016-5085(19)33930-7 · DOI
- Spence R W, 1976, Effect on gastric acid output of prolonged treatment with cimetidine in duodenal ulcer patients, Gut, 17, 831
- Barbezeat G O, 1977, Cimetidine: proceedings of the second international symposium on H2‐receptor antagonists, 110
- Crean G P, 1977, Cimetidine: proceedings of the second international symposium on H2‐receptor antagonists, 122
- 10.1136/gut.24.1.61 · doi:10.1136/gut.24.1.61
- Londong W, 1983, Dose‐response study of omeprazole on meal‐stimulated gastric acid secretion and gastrin release, Gastroenterology, 85, 1373, 10.1016/S0016-5085(83)80020-1 · doi:10.1016/s0016-5085(83)80020-1
- 10.1136/gut.25.9.957 · DOI · Paper page
- Festen H P M, 1984, The effect of oral omeprazole of serum gastrin and serum pepsinogen I levels, Gastroenterology, 87, 1030, 10.1016/S0016-5085(84)80061-X · doi:10.1016/s0016-5085(84)80061-x
- Allen J M, 1984, Effect of single dose of omeprazole on the gastrointestinal peptide response to food, Hepato-gastroenterol, 31, 44
- Muller P, 1984, Vierwochige omeprazolgabe: einfluss auf saureverhalten und basale hormonspiegel, Z Gastroenterol, 22, 236
- 10.1111/j.1365-2036.1987.tb00608.x · DOI
- Ekman L, 1985, Omeprazole book one, 53
- 10.1111/j.1365-2036.1987.tb00609.x · doi:10.1111/j.1365-2036.1987.tb00609.x
- 10.1016/0016-5085(86)90938-8 · DOI · Paper page
- 10.3109/00365528609090896 · doi:10.3109/00365528609090896
- 10.1111/j.1365-2036.1987.tb00622.x · doi:10.1111/j.1365-2036.1987.tb00622.x
- 10.1016/0016-5085(85)90451-2 · DOI
- 10.1007/BF01403840 · doi:10.1007/bf01403840
- Bryant M G, 1982, Radioimmunoassay of gut regulatory peptides, 51
- Pocock S J, 1984, Clinical trials, 110
- 10.1016/0016-5085(78)90763-1 · doi:10.1016/0016-5085(78)90763-1
- Sewing K‐F, 1978, Effect of one month's treatment with cimetidine on gastric secretion and serum gastrin and pepsinogen levels, Gastroenterology, 74, 276
- 10.3109/00365527909179895 · doi:10.3109/00365527909179895
- 10.1007/BF01299830 · doi:10.1007/bf01299830
- Lombardo R, 1983, Long‐term ranitidine treatment for the maintenance of duodenal ulcer, Int J Tissue Reactions, 5, 323
- Santana I A, 1985, Long‐lasting decrease of 24 hour intragastric acidity with novel H2‐antagonists CP 57, 361, Gastroenterology, 88, 1569A
- Santana I A, Intragastric acidity during duodenal ulcer maintenance treatment with H2‐blockers. I, Clin Nutr Gastroenterol, 1, 122
- Smout A J P M, 1985, Effects of cimetidine and ranitidine on interdigestive and postprandial esophageal sphincter pressures and plasma gastrin levels in normal subjects, Gastroenterology, 88, 557, 10.1016/0016-5085(85)90521-9 · doi:10.1016/0016-5085(85)90521-9
- Santana I A, 1986, Effect of oral famotidine on 24‐hour intragastric acidity, Postgrad Med J, 62, 39
- Yoshida Y, 1986, Chronological effect of histamine H2‐receptor antagonist ranitidine and serum gastrin response in gastric ulcer patients, Jap J Gastroenterol, 83, 33
- Sharma B K, 1983, Intragastric acidity after treatment with omeprazole, Gut, 24, A973
- Larsson L I, 1978, Mixed endocrine gastric tumors associated with hypergastrinaemia of antral origin, Am J Pathol, 93, 53
- 10.3109/01913128009141444 · doi:10.3109/01913128009141444
- 10.1016/S0140-6736(85)91727-1 · doi:10.1016/s0140-6736(85)91727-1
- 10.1016/0016-5085(85)90131-3 · DOI · Paper page
- 10.7326/0003-4819-99-6-761 · DOI · Paper page
- 10.3109/00365528609003087 · DOI
Cited by
Walan, A., Bader, J.-P., Classen, M., Lamers, C. B. H. W., Piper, D. W., Rutgersson, K., & Eriksson, S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901123200201 · Cited by 380
Andersson, T. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631010-00002 · Cited by 326
Omeprazole: An Updated Review of its Pharmacology and Therapeutic Use in Acid-Related Disorders
McTavish, D., Buckley, M. M.-T., & Heel, R. C. (1991) · Drugs · doi:10.2165/00003495-199142010-00008 · Cited by 282
Gastrin and colorectal cancer: A prospective study
Thorburn*, C. M., Friedman‡, G. D., Dickinson§, C. J., Vogelman∥, J. H., Orentreich∥, N., & Parsonnet*, #. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70193-3 · Cited by 267
Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors
Baekdal, J., Krogh, J., Klose, M., Holmager, P., Langer, S. W., Oturai, P., Kjaer, A., Federspiel, B., Hilsted, L., Rehfeld, J. F., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10110881 · Cited by 17
“In patients who cannot discontinue PPI, H2 receptor antagonist (H2RA) replacement may be tried during one or two weeks of PPI discontinuation [35] as H2RA affects gastric acidity, gastrin and CgA levels to a lesser extent than PPI [36].”
Background
Metadata
- Authors
- LANZON‐MILLER, S., POUNDER, R. E., HAMILTON, M. R., BALL, S., CHRONOS, N. A. F., RAYMOND, F., OLAUSSON, M., & CEDERBERG, C.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1987-06
- Volume
- 1
- Issue
- 3
- Pages
- 239-251
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2156638426
- Cited by
- 188
- References
- 0
- FWCI
- 23.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Twenty‐four‐hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. https://app.cochat.ai/papers/10.1111/j.1365-2036.1987.tb00623.x
- The paper
- LANZON‐MILLER, S., POUNDER, R. E., HAMILTON, M. R., BALL, S., CHRONOS, N. A. F., RAYMOND, F., OLAUSSON, M., & CEDERBERG, C. (1987). Twenty‐four‐hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.1987.tb00623.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.